Filing Details
- Accession Number:
- 0001773751-23-000286
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-06 18:41:42
- Reporting Period:
- 2023-12-04
- Accepted Time:
- 2023-12-06 18:41:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837815 | Melissa Baird | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-12-04 | 3,624 | $0.40 | 407,473 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-12-04 | 9,133 | $8.81 | 400,840 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-12-05 | 9,133 | $8.78 | 391,707 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-12-06 | 9,133 | $9.02 | 382,574 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-12-04 | 3,624 | $0.00 | 3,624 | $0.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 810,664 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.
- Includes 2,500 shares acquired on November 20, 2023, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.65 - $8.915. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.64 - $8.845. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.88 - $9.22. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.
Billionaire Hedge Funds
